A Mushroom-Derived Polysaccharopeptide Engaged CB2-Related Measures in a Rat Morphine Model

A rat inflammatory-pain experiment linked a Trametes versicolor polysaccharopeptide to reduced morphine-related adaptation and changes in CB2-associated measures. It did not test an oral mushroom supplement or establish an adjunctive treatment in patients.

The preparation and route were experimental

Researchers induced inflammatory joint pain and administered morphine intrathecally. The polysaccharopeptide preparation, TPSP, was also administered intrathecally for three weeks. Delivery into the spinal fluid compartment is not equivalent to eating a mushroom or taking a commercially available extract.

Behavioral and molecular outcomes were reported

TPSP reduced reported dependence and acute-withdrawal outcomes and improved mechanical and heat-response measures. These effects accompanied increased CB2 receptor and beta-endorphin measures and reductions in selected inflammatory mediators. The molecular associations do not alone establish that one change fully mediated every behavioral outcome.

Clinical language needs a species boundary

Although the authors proposed an adjunctive strategy, the described experiment used rats. The abstract does not report a clinical trial, demonstrate human safety or identify a suitable consumer preparation. CB2 involvement also does not make TPSP interchangeable with THC or cannabis.

The study is relevant to cannabinoid-system research because a non-cannabis preparation was associated with CB2-related changes. Its actual contribution is preclinical and route-specific. It should not be presented as evidence that an over-the-counter mushroom product prevents opioid tolerance or withdrawal.

Related: interpreting cannabis tolerance claims.

Research cited

Wang K; Wang Z; Cui R; Chu H. Polysaccharopeptide from Trametes versicolor blocks inflammatory osteoarthritis pain-morphine tolerance effects via activating cannabinoid type 2 receptor. International journal of biological macromolecules (2019). doi:10.1016/j.ijbiomac.2018.12.212. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC Changed Shock-Avoidance Outcomes More Consistently Than Response Rates in Rats

A 1976 rat experiment found highly variable changes in lever-press rates after THC, while received shocks increased more reliably at first. Counting responses alone would have missed the more consistent change in task success. The animals were extensively trained Rats performed free-operant avoidance, where responses reduced exposure to shocks, during…

Spread the love

Read Article: THC Changed Shock-Avoidance Outcomes More Consistently Than Response Rates in Rats

THC-Associated Avoidance Learning in Rats Depended on the Drug State at Testing

A 1976 Y-maze study found that selected THC conditions improved acquisition of an avoidance response, but performance fell when the drug was removed and recovered when it returned. That pattern is consistent with state-dependent learning, not general cognitive enhancement. Dose and task defined the reported improvement A lower THC dose…

Spread the love

Read Article: THC-Associated Avoidance Learning in Rats Depended on the Drug State at Testing

Prior Cannabis-Smoke Exposure Changed the Response to Injected THC in Rats

A 1976 rat study found that repeated cannabis-smoke exposure changed the later movement response to injected THC. The result supports cross-route adaptation while preserving differences between male and female challenge responses. Inhalation preceded a different-route challenge Male and female rats received cannabis or placebo smoke every other day for thirty-two…

Spread the love

Read Article: Prior Cannabis-Smoke Exposure Changed the Response to Injected THC in Rats

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us